Dr. Janet Anderson is a human health toxicologist and environmental risk assessor with 15 years of experience providing toxicology expertise and consultation to federal agencies and industry. She specializes in risk communication, including the translation of human health toxicology data into state and federal regulatory policy decisions. She performs critical reviews of federal and state risk assessment guidance and regulations. She has also provided litigation consulting support and served as an expert testifying witness.
Dr. Anderson is a nationally recognized leader in unregulated and emerging contaminants, such as per- and polyfluoroalkyl substances (PFAS), 1,4‑dioxane, and 1,2,3-trichloropropane. With in-depth knowledge of federal and state environmental guidance and policies pertaining to this class of compounds, she has developed strategies to communicate their risks, mitigate their human health impacts, and address associated environmental liability for both private and public sector clients. She tracks the dynamic regulatory changes for emerging contaminants in the U.S. and internationally, offering clients the technical basis for disparate guidelines worldwide. She has extensive experience developing and communicating risk management strategies for multi‑stakeholder groups.
Previously, as a civilian government employee, Dr. Anderson led the U.S. Air Force (USAF) Emerging Contaminants program, where she developed programmatic recommendations on environmental regulations and cleanup standards. She also served as a member of the federal interagency review team providing consultation and expert review on nearly all noncancer and cancer toxicology assessments and/or guidance documents produced by federal agencies. As a postdoctoral fellow for the EPA Office of Research and Development National Center for Environmental Assessment, she managed numerous Superfund chemical assessments and served as a team member for Integrated Risk Information System (IRIS) assessments.
Dr. Anderson is a diplomate of the American Board of Toxicology and an active member of the Society of Toxicology. A skilled communicator, she is often an invited speaker at high-level scientific conferences, regulatory meetings, webinars, and community stakeholder meetings, where she applies her expertise in noncancer and cancer chemical toxicity and risk communication.Back to List